✨ FREE 225-Question NAPLEX Practice Test! Just create a FREE Pyrls account at https://t.co/7FKmFCvMK1 (or already have one 😊) Being a PharmD grad is expensive... license fees, boards fees, test prep materials fees, interview travel, oh and STUDENT LOANS. We know, we've been

FDA Approves Reformulated Ranitidine

FDA Approves REDEMPLO (plozasiran) for Familial Chylomicronemia Syndrome (FCS)

2026 Global Strategy for Prevention, Diagnosis, and Management of COPD (2026 GOLD Report) Published

FDA Requests Labeling Changes for Menopausal Hormone Therapies to Clarify Benefit/Risk Considerations

FDA Approves CAPLYTA (lumateperone) as an Add-On for Major Depressive Disorder in Adults

FDA Approves LINZESS (linaclotide) for Children Ages 7 Years and Older With IBS-C

FDA Approves LYNKUET (elinzanetant) to Treat Vasomotor Symptoms of Menopause

FDA Approves CONTEPO (IV fosfomycin) for the Treatment of Complicated UTI

FDA Approves TEZSPIRE (tezepelumab-ekko) for Chronic Rhinosinusitis with Nasal Polyps

FDA Approves RYBELSUS (oral semaglutide) for MACE Risk Reduction

FDA Approves JASCAYD (nerandomilast) to Treat Idiopathic Pulmonary Fibrosis

FDA Approves RHAPSIDO (remibrutinib) for the Treatment of Chronic Spontaneous Urticaria

Chemo Body: Chemotherapy Side Effects 💊 Free PDF download available on the Pyrls website or app 🔮

FDA Removes REMS for CAPRELSA (vandetanib)

Updated Hypertension Pharmacotherapy Review and Chart 📊 Available in the Pyrls website or app 🔮

FDA Approves KEYTRUDA QLEX for Subcutaneous Injection Across Most Solid Tumor Indications for KEYTRUDA

FDA Approves OPZELURA (ruxolitinib) for Children Ages 2-11 Years with Atopic Dermatitis

FDA Approves ENBUMYST (bumetanide nasal spray) for the Treatment of Certain Types of Edema

FDA Approves INLEXZO (intravesical gemtricitabine) for the Treatment of Certain Bladder Cancers

Updated Influenza Vaccine Recommendations (2025-2026) 💉 Free download available in the Pyrls website or app 🔮